Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
eqs_en 
0 04.02.20
Kaufman & Broad SA: Sale-before-completion agreement for office space in Paris
Kaufman & Broad SA: Sale-before-completion agreement for office space in Paris
Kaufman & Broad SA: Sale-before-completion agreement for office space in Paris
eqs_en 
0 31.01.20
Kaufman & Broad SA: 2019 Annual Results
Kaufman & Broad SA: 2019 Annual Results
Kaufman & Broad SA: 2019 Annual Results
eqs_en 
0 30.01.20
DGAP-News: Abivax to Host Satellite Symposium at 15th Congress of the European Crohn's and Colitis Organization (ECCO) in Vienna
DGAP-News: Abivax to Host Satellite Symposium at 15th Congress of the European Crohn's and Colitis Organization (ECCO) in Vienna
DGAP-News: Abivax to Host Satellite Symposium at 15th Congress of the European Crohn's and Colitis Organization (ECCO) in Vienna
eqs_en 
0 28.01.20
DGAP-News: Abivax veranstaltet Satellite-Symposium auf dem 15. Kongress der 'European Crohn's and Colitis Organisation' (ECCO) in Wien
DGAP-News: Abivax veranstaltet Satellite-Symposium auf dem 15. Kongress der 'European Crohn's and Colitis Organisation' (ECCO) in Wien
DGAP-News: Abivax veranstaltet Satellite-Symposium auf dem 15. Kongress der 'European Crohn's and Colitis Organisation' (ECCO) in Wien
eqs_de 
0 28.01.20
Voltalia SA: half-year statement of the liquidity contract -as of December 31, 2019
Voltalia SA: half-year statement of the liquidity contract -as of December 31, 2019
Voltalia SA: half-year statement of the liquidity contract -as of December 31, 2019
eqs_en 
0 28.01.20
Voltalia SA: total number of shares and voting rights in the share capital as of December 31, 2019
Voltalia SA: total number of shares and voting rights in the share capital as of December 31, 2019
Voltalia SA: total number of shares and voting rights in the share capital as of December 31, 2019
eqs_en 
0 27.01.20
Voltalia SA: Highest quarterly revenues ever - Contracted future revenues climb over €5 billion
Voltalia SA: Highest quarterly revenues ever - Contracted future revenues climb over €5 billion
Voltalia SA: Highest quarterly revenues ever - Contracted future revenues climb over €5 billion
eqs_en 
0 22.01.20
Rubis to partner with I Squared Capital in Rubis Terminal
Rubis to partner with I Squared Capital in Rubis Terminal
Rubis to partner with I Squared Capital in Rubis Terminal
eqs_en 
0 21.01.20
DGAP-News: Abivax erhält FDA-Genehmigung für den Start klinischer Studien mit ABX464 in den USA zur Behandlung mittelschwerer bis schwerer Colitis ulcerosa
DGAP-News: Abivax erhält FDA-Genehmigung für den Start klinischer Studien mit ABX464 in den USA zur Behandlung mittelschwerer bis schwerer Colitis ulcerosa
DGAP-News: Abivax erhält FDA-Genehmigung für den Start klinischer Studien mit ABX464 in den USA zur Behandlung mittelschwerer bis schwerer Colitis ulcerosa
eqs_de 
0 20.01.20
DGAP-News: Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to treat Moderate to Severe Ulcerative Colitis
DGAP-News: Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to treat Moderate to Severe Ulcerative Colitis
DGAP-News: Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to treat Moderate to Severe Ulcerative Colitis
eqs_en 
0 20.01.20
Rubis: Half-year statement on Rubis' liquidity contract with Exane BNP Paribas
Rubis: Half-year statement on Rubis' liquidity contract with Exane BNP Paribas
Rubis: Half-year statement on Rubis' liquidity contract with Exane BNP Paribas
eqs_en 
0 20.01.20
DGAP-News: ABIVAX: Finanzkalender 2020
DGAP-News: ABIVAX: Finanzkalender 2020
DGAP-News: ABIVAX: Finanzkalender 2020
eqs_de 
0 20.01.20
Showroomprive.com: HALF YEAR ACHIEVEMENT REPORT ON LIQUIDITY CONTRACT
Showroomprive.com: HALF YEAR ACHIEVEMENT REPORT ON LIQUIDITY CONTRACT
Showroomprive.com: HALF YEAR ACHIEVEMENT REPORT ON LIQUIDITY CONTRACT
eqs_en 
0 09.01.20
Pharnext Announces Encouraging Data from Open-Label Phase 3 Extension Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A)
Pharnext Announces Encouraging Data from Open-Label Phase 3 Extension Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A)
Pharnext Announces Encouraging Data from Open-Label Phase 3 Extension Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A)
eqs_en 
0 06.01.20
RUBIS: Disclosure of the total number of voting rights and of the number of shares on 12/31/2019
RUBIS: Disclosure of the total number of voting rights and of the number of shares on 12/31/2019
RUBIS: Disclosure of the total number of voting rights and of the number of shares on 12/31/2019
eqs_en 
0 06.01.20
Kaufman & Broad SA: Half-year liquidity contract statement for Kaufman & Broad
Kaufman & Broad SA: Half-year liquidity contract statement for Kaufman & Broad
Kaufman & Broad SA: Half-year liquidity contract statement for Kaufman & Broad
eqs_en 
0 06.01.20
Correction of a release from 02.01.2020, 09:55 CET/CEST - Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT
Correction of a release from 02.01.2020, 09:55 CET/CEST - Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT
Correction of a release from 02.01.2020, 09:55 CET/CEST - Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT
eqs_en 
0 03.01.20
Kaufman & Broad SA: Invitation to 2019 annual results
Kaufman & Broad SA: Invitation to 2019 annual results
Kaufman & Broad SA: Invitation to 2019 annual results
eqs_en 
0 02.01.20
Kaufman & Broad SA: Declaration of transactions 31 december 2019
Kaufman & Broad SA: Declaration of transactions 31 december 2019
Kaufman & Broad SA: Declaration of transactions 31 december 2019
eqs_en 
0 02.01.20
Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT
Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT
Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT
eqs_en 
0 02.01.20
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
eqs_en 
0 02.01.20
Kaufman & Broad SA: Declaration of transactions 30 december 2019
Kaufman & Broad SA: Declaration of transactions 30 december 2019
Kaufman & Broad SA: Declaration of transactions 30 december 2019
eqs_en 
0 30.12.19
ALD ANNOUNCES SALE OF ALD FORTUNE AUTO LEASING & RENTING IN CHINA
ALD ANNOUNCES SALE OF ALD FORTUNE AUTO LEASING & RENTING IN CHINA
ALD ANNOUNCES SALE OF ALD FORTUNE AUTO LEASING & RENTING IN CHINA
eqs_en 
0 20.12.19
Voltalia SA: total number of shares and voting rights in the share capital as of November 30, 2019
Voltalia SA: total number of shares and voting rights in the share capital as of November 30, 2019
Voltalia SA: total number of shares and voting rights in the share capital as of November 30, 2019
eqs_en 
0 20.12.19